Ömer Kuru
Research Subjects
Ömer Kuru has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Esma Demirhan
Univ Hlth Sci Turkey, Prof Dr Cemil Tascioglu City Hosp, Clin Phys Med & Rehabil, Istanbul, Turkiye
11 shared publications - Sevgi Atar
Univ Hlth Sci Turkey, Prof Dr Cemil Tascioglu City Hosp, Clin Phys Med & Rehabil, Istanbul, Turkiye
11 shared publications - Ayhan Bilgici
ONDOKUZ MAYIS ÜNİVERSİTESİ, TIP FAKÜLTESİ
3 shared publications - Dilara Ekici Zincirci
Department of Physical Medicine and Rehabilitation, Istanbul Medipol University, 34230 Istanbul, Türkiye
3 shared publications - Nur Ferhatlar
Viranşehir devlet hastanesi
3 shared publications - Yasemin Ulus
Department of Physical Medicine and Rehabilitation, Medical Faculty of Ondokuz Mayıs University, Samsun, Turkey
3 shared publications
Latest Publications
- 23 September 2026
- Published by Taylor & Francis in Disability and Rehabilitation
- p. 1-10
Validity, reliability, and interpretability of the Turkish version of the Copenhagen Hip and Groin Outcome Score (HAGOS)
Hip osteoarthritis (OA) is a major cause of pain and disability in Western societies. Although it is particularly common in older age groups, most cases are reported to occur before retirement [1]....
- 23 September 2026
- Published by Taylor & Francis in Disability and Rehabilitation
- p. 1-10
Validity, reliability, and interpretability of the Turkish version of the Copenhagen Hip and Groin Outcome Score (HAGOS)
Hip osteoarthritis (OA) is a major cause of pain and disability in Western societies. Although it is particularly common in older age groups, most cases are reported to occur before retirement [1]....
- Open Access
- 1 July 2026
- Published by Baycinar Tibbi Yayincilik in Ağrı - The Journal of The Turkish Society of Algology
- Vol. 38 (3) , 166-172
Post-traumatic complex regional pain syndrome type 1: Risk factors and the potential clinical relevance of magnesium depletion score
Background: This study aimed to evaluate whether the magnesium depletion score (MDS), an indicator of magnesium deficiency, is associated with the development of complex regional pain syndrome type 1 (CRPS-1) in patients with traumatic extremity injuries. Patients and Methods: Between November 2024 and May 2025, a total of 117 patients who suffered from traumatic extremity injuries were included. Demographic and clinical data of the patients were collected and recorded, and the MDS was calculated. Age, sex, body mass index (BMI), smoking status, alcohol consumption, diabetes, hypertension, duration of immobilization, MDS, and injury-related characteristics were evaluated as potential risk factors for CRPS-1 development. Results: Of the patients, 40 were male and 77 were female with a mean age of 51.9 ± 15.01 (range, 20 to 91 years). In a total of 42.7% of patients with traumatic extremity injuries, CRPS-1 developed. The female-to-male ratio was higher among patients with CRPS-1 than among those without. The MDS, hypertension, diabetes, smoking, and alcohol consumption were not found to be independent risk factors. However, prolonged immobilization (more than one month) was found to be an independent risk factor for the development of CRPS-1. Conclusion: Our study results suggest that the MDS score is not a risk factor for developing CRPS-1, but immobilization for more than one month significantly increases the risk. Taken together, these findings indicate that the duration of immobilization following injury may be a more decisive factor in the development of CRPS-1 than demographic and clinical characteristics.
- 1 July 2026
- Published by Baycinar Tibbi Yayincilik in Ağrı - The Journal of The Turkish Society of Algology
- Vol. 38 (3) , 166-172
Open AccessPost-traumatic complex regional pain syndrome type 1: Risk factors and the potential clinical relevance of magnesium depletion score
Background: This study aimed to evaluate whether the magnesium depletion score (MDS), an indicator of magnesium deficiency, is associated with the development of complex regional pain syndrome type 1 (CRPS-1) in patients with traumatic extremity injuries. Patients and Methods: Between November 2024 and May 2025, a total of 117 patients who suffered from traumatic extremity injuries were included. Demographic and clinical data of the patients were collected and recorded, and the MDS was calculated. Age, sex, body mass index (BMI), smoking status, alcohol consumption, diabetes, hypertension, duration of immobilization, MDS, and injury-related characteristics were evaluated as potential risk factors for CRPS-1 development. Results: Of the patients, 40 were male and 77 were female with a mean age of 51.9 ± 15.01 (range, 20 to 91 years). In a total of 42.7% of patients with traumatic extremity injuries, CRPS-1 developed. The female-to-male ratio was higher among patients with CRPS-1 than among those without. The MDS, hypertension, diabetes, smoking, and alcohol consumption were not found to be independent risk factors. However, prolonged immobilization (more than one month) was found to be an independent risk factor for the development of CRPS-1. Conclusion: Our study results suggest that the MDS score is not a risk factor for developing CRPS-1, but immobilization for more than one month significantly increases the risk. Taken together, these findings indicate that the duration of immobilization following injury may be a more decisive factor in the development of CRPS-1 than demographic and clinical characteristics.
- Open Access
- 30 June 2025
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 35 (3) , 455-461
Associations Between Sleep Quality and Shoulder Pain And Function
Objectives: The most common cause of shoulder pain is rotator cuff disease (RCD). Nocturnal pain is common in patients and is one of the main reasons for visiting a doctor. The aim of this study is to evaluate the effect of shoulder function and nocturnal pain on sleep quality in patients with RCD. Material and Methods: Ninety-three patients who presented to the outpatient clinic with RCD-related shoulder pain between October 2024 and December 2024 were included in the study. Shoulder function was assessed by the Penn Shoulder Score (PSS) and sleep quality by the Pittsburgh Sleep Quality Index (PSQI). Patients' magnetic resonance imaging (MRI) findings were recorded. Results: The mean PSQI score was 6.7±2.7. In the group with better sleep quality, the PSS was higher and the Penn Pain subscore was lower (p
- 30 June 2025
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 35 (3) , 455-461
Open AccessAssociations Between Sleep Quality and Shoulder Pain And Function
Objectives: The most common cause of shoulder pain is rotator cuff disease (RCD). Nocturnal pain is common in patients and is one of the main reasons for visiting a doctor. The aim of this study is to evaluate the effect of shoulder function and nocturnal pain on sleep quality in patients with RCD. Material and Methods: Ninety-three patients who presented to the outpatient clinic with RCD-related shoulder pain between October 2024 and December 2024 were included in the study. Shoulder function was assessed by the Penn Shoulder Score (PSS) and sleep quality by the Pittsburgh Sleep Quality Index (PSQI). Patients' magnetic resonance imaging (MRI) findings were recorded. Results: The mean PSQI score was 6.7±2.7. In the group with better sleep quality, the PSS was higher and the Penn Pain subscore was lower (p
- Open Access
- 24 February 2025
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 71 (1) , 122-126
Spinal segmental myoclonus following ultrasound-guided suprascapular nerve block: A case report
Herein, we reported a case of spinal myoclonus following an ultrasound-guided suprascapular nerve block. A 58-year-old male patient who had a diagnosis of calcific tendinitis inside the right supraspinatus tendon received a right suprascapular nerve block (3 mL of 2% prilocaine mixed with 2 mL of 1% lidocaine) under the guidance of ultrasound. Sudden, painless, and involuntary movements began in the upper extremity 10 min after the intervention. Three months after the injection, the involuntary movements were entirely stopped. Involuntary, painless, and brief muscle jerks may be suggestive of myoclonus after interventions with local anesthetics.
- 24 February 2025
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 71 (1) , 122-126
Open AccessSpinal segmental myoclonus following ultrasound-guided suprascapular nerve block: A case report
Herein, we reported a case of spinal myoclonus following an ultrasound-guided suprascapular nerve block. A 58-year-old male patient who had a diagnosis of calcific tendinitis inside the right supraspinatus tendon received a right suprascapular nerve block (3 mL of 2% prilocaine mixed with 2 mL of 1% lidocaine) under the guidance of ultrasound. Sudden, painless, and involuntary movements began in the upper extremity 10 min after the intervention. Three months after the injection, the involuntary movements were entirely stopped. Involuntary, painless, and brief muscle jerks may be suggestive of myoclonus after interventions with local anesthetics.
- 1 April 2024
- Published by Galenos Yayinevi in Turkish Journal of Osteoporosis
- Vol. 30 (1) , 49-54
Comparison of Functional Status and Depression in Younger and Older Patients with Chronic Low Back Pain: A Multi-center Crosssectional Survey
- 1 April 2024
- Published by Galenos Yayinevi in Turkish Journal of Osteoporosis
- Vol. 30 (1) , 49-54
Comparison of Functional Status and Depression in Younger and Older Patients with Chronic Low Back Pain: A Multi-center Crosssectional Survey
- Open Access
- 31 March 2024
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 39 (1) , 020-032
Frequency of fibromyalgianess in patients with rheumatoid arthritis and ankylosing spondylitis: A multicenter study of Turkish League Against Rheumatism (TLAR) network
Objectives: This study aimed to evaluate the frequency of fibromyalgianess, fibromyalgia syndrome (FS), and widespread pain in patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) and their relationship with clinical and demographic parameters. Patients and methods: This cross-sectional multicenter trial was performed in 14 centers across Türkiye between June 2018 and November 2019. Out of 685 patients recruited from the accessible population, 661 patients (342 RA, 319 AS; 264 males, 397 females; mean age: 48.1±12.9 years; range, 17 to 88 years) met the selection criteria. In these cohorts, those who did not meet the criteria for FS and had widespread pain (widespread pain index ≥7) were evaluated as a separate group. Clinical status and demographic parameters of patients in both cohorts were evaluated as well as the evaluations of RA and AS patients with widespread pain (widespread pain index ≥7) and RA and AS patients with FS groups. In addition, correlations between polysymptomatic distress scale (PSD) scores and Visual Analog Scale (VAS), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), and Disease Activity Score using 28 joint counts for RA patients and VAS, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Ankylosing Spondylitis Disease Activity Score (ASDAS) for AS patients were analyzed. Results: Frequencies of patients with FS and patients who had PSD scores ≥12 were 34.1% and 44.4% in all RA patients, respectively. Moreover, FS and PSD scores ≥12 were found in 29.2% and 36.9% of all AS patients, respectively. PSD scores of RA patients with FS were higher than all RA patients and RA patients with widespread pain. SDAI and CDAI scores of RA patients with FS were higher than all RA patients and RA patients with widespread pain. Similarly, PSD scores of AS patients with FS were higher than all AS patients and AS patients with widespread pain. ASDAS-erythrocyte sedimentation rate and BASDAI scores of AS patients with FS were found higher than all AS patients and AS patients with widespread pain. Conclusion: Disease activity scores, including pain in RA and AS, were higher in the presence of FS or fibromyalgianess. It may be related to clinical parameters, but cohort studies with long-term follow-up are needed to reveal causality. Additionally, to avoid overtreatment, coexistence of fibromyalgianess should be kept in mind in patients who have inflammatory diseases such as RA and AS, particularly with intractable widespread pain.
- 31 March 2024
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 39 (1) , 020-032
Open AccessFrequency of fibromyalgianess in patients with rheumatoid arthritis and ankylosing spondylitis: A multicenter study of Turkish League Against Rheumatism (TLAR) network
Objectives: This study aimed to evaluate the frequency of fibromyalgianess, fibromyalgia syndrome (FS), and widespread pain in patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) and their relationship with clinical and demographic parameters. Patients and methods: This cross-sectional multicenter trial was performed in 14 centers across Türkiye between June 2018 and November 2019. Out of 685 patients recruited from the accessible population, 661 patients (342 RA, 319 AS; 264 males, 397 females; mean age: 48.1±12.9 years; range, 17 to 88 years) met the selection criteria. In these cohorts, those who did not meet the criteria for FS and had widespread pain (widespread pain index ≥7) were evaluated as a separate group. Clinical status and demographic parameters of patients in both cohorts were evaluated as well as the evaluations of RA and AS patients with widespread pain (widespread pain index ≥7) and RA and AS patients with FS groups. In addition, correlations between polysymptomatic distress scale (PSD) scores and Visual Analog Scale (VAS), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), and Disease Activity Score using 28 joint counts for RA patients and VAS, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Ankylosing Spondylitis Disease Activity Score (ASDAS) for AS patients were analyzed. Results: Frequencies of patients with FS and patients who had PSD scores ≥12 were 34.1% and 44.4% in all RA patients, respectively. Moreover, FS and PSD scores ≥12 were found in 29.2% and 36.9% of all AS patients, respectively. PSD scores of RA patients with FS were higher than all RA patients and RA patients with widespread pain. SDAI and CDAI scores of RA patients with FS were higher than all RA patients and RA patients with widespread pain. Similarly, PSD scores of AS patients with FS were higher than all AS patients and AS patients with widespread pain. ASDAS-erythrocyte sedimentation rate and BASDAI scores of AS patients with FS were found higher than all AS patients and AS patients with widespread pain. Conclusion: Disease activity scores, including pain in RA and AS, were higher in the presence of FS or fibromyalgianess. It may be related to clinical parameters, but cohort studies with long-term follow-up are needed to reveal causality. Additionally, to avoid overtreatment, coexistence of fibromyalgianess should be kept in mind in patients who have inflammatory diseases such as RA and AS, particularly with intractable widespread pain.
- Open Access
- 28 September 2023
- Published by Anadolu Klinigi Tip Bilimleri Dergisi in Anadolu Kliniği Tıp Bilimleri Dergisi
- Vol. 28 (3) , 252-258
Aksiyal spondiloartritli hastalarda D vitamini eksikliğinin yorgunluk ve depresyon üzerine etkisi
Aim: In this study, we aimed to examine the effect of vitamin D deficiency on fatigue and depression in patients with axial spondyloarthritis (Ax-SpA). Methods: This cross-sectional study included 141 Ax-SpA patients. Demographic information of the patients was recorded. The Hospital Anxiety and Depression Scale, Visual Analog Scale, Fatigue Severity Scale, and Ankylosing Spondylitis Disease Activity Score were used to evaluate depression, anxiety, pain, fatigue, and disease activity levels, respectively. Vitamin D levels were classified as deficiency ( 20 ng/ml). Results: A total of 141 patients enrolled in the study (67 female and 74 male). Vitamin D levels were deficient in 14.2%, insufficient in 56%, and sufficient in 29.8% of cases. In the evaluation of fatigue, 20.6% of the cases were evaluated as normal, 60.3% as tired, and 19.1% as chronically tired. Although fatigue was detected in 79.4% of Ax-SpA patients, fatigue scores were not associated with vitamin D deficiency (p=0.191). There were no significant differences between the vitamin D groups (deficiency, insufficiency, and normal) in fatigue and depression scores, sex, disease duration, and activity. Conclusion: Vitamin D deficiency is not associated with fatigue, depression, or disease activity in patients with Ax-Spa. Regardless of vitamin D deficiency, patients with depression and fatigue should be evaluated and managed appropriately, and the management of vitamin D deficiency should not be ignored.
- 28 September 2023
- Published by Anadolu Klinigi Tip Bilimleri Dergisi in Anadolu Kliniği Tıp Bilimleri Dergisi
- Vol. 28 (3) , 252-258
Open AccessAksiyal spondiloartritli hastalarda D vitamini eksikliğinin yorgunluk ve depresyon üzerine etkisi
Aim: In this study, we aimed to examine the effect of vitamin D deficiency on fatigue and depression in patients with axial spondyloarthritis (Ax-SpA). Methods: This cross-sectional study included 141 Ax-SpA patients. Demographic information of the patients was recorded. The Hospital Anxiety and Depression Scale, Visual Analog Scale, Fatigue Severity Scale, and Ankylosing Spondylitis Disease Activity Score were used to evaluate depression, anxiety, pain, fatigue, and disease activity levels, respectively. Vitamin D levels were classified as deficiency ( 20 ng/ml). Results: A total of 141 patients enrolled in the study (67 female and 74 male). Vitamin D levels were deficient in 14.2%, insufficient in 56%, and sufficient in 29.8% of cases. In the evaluation of fatigue, 20.6% of the cases were evaluated as normal, 60.3% as tired, and 19.1% as chronically tired. Although fatigue was detected in 79.4% of Ax-SpA patients, fatigue scores were not associated with vitamin D deficiency (p=0.191). There were no significant differences between the vitamin D groups (deficiency, insufficiency, and normal) in fatigue and depression scores, sex, disease duration, and activity. Conclusion: Vitamin D deficiency is not associated with fatigue, depression, or disease activity in patients with Ax-Spa. Regardless of vitamin D deficiency, patients with depression and fatigue should be evaluated and managed appropriately, and the management of vitamin D deficiency should not be ignored.
- 1 August 2023
- Published by Galenos Yayinevi in Turkish Journal of Osteoporosis
- Vol. 29 (2) , 84-88
Retrospective Comparison of the Effect of IL-17 Blocker Therapy and Anti-TNF Agent Therapy on Bone Mineral Density in Axial Spondyloartropathy Patients
- 1 August 2023
- Published by Galenos Yayinevi in Turkish Journal of Osteoporosis
- Vol. 29 (2) , 84-88
Retrospective Comparison of the Effect of IL-17 Blocker Therapy and Anti-TNF Agent Therapy on Bone Mineral Density in Axial Spondyloartropathy Patients
- 1 February 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (1) , 57-61
Impact of Trigger Point Dry Needling on Neck Pain, Sleep, and Depression in Patients with Fibromyalgia
- 1 February 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (1) , 57-61
Impact of Trigger Point Dry Needling on Neck Pain, Sleep, and Depression in Patients with Fibromyalgia